Skip to site menu Skip to page content
Curia Global
Go back

Curia’s Approach to Regulatory Compliance in Japan

This whitepaper provides an overview of Japan’s regulatory requirements for active pharmaceutical ingredients, including J-DMF registration, Foreign Manufacturer Accreditation, Japanese GMP expectations and PMDA review. It also outlines the principal steps international API manufacturers must address when preparing to supply the Japanese market.
Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Related Content